nodes	percent_of_prediction	percent_of_DWPC	metapath
Zopiclone—PTGS1—malignant glioma	0.635	1	CbGaD
Zopiclone—Behavior disorder—Temozolomide—malignant glioma	0.0145	0.0728	CcSEcCtD
Zopiclone—Eszopiclone—PTGS1—malignant glioma	0.00515	1	CrCbGaD
Zopiclone—Hyperacusis—Temozolomide—malignant glioma	0.00449	0.0225	CcSEcCtD
Zopiclone—Abnormal behaviour—Temozolomide—malignant glioma	0.00449	0.0225	CcSEcCtD
Zopiclone—TSPO—blood vessel—malignant glioma	0.00298	0.0405	CbGeAlD
Zopiclone—Myasthenia—Carmustine—malignant glioma	0.00276	0.0138	CcSEcCtD
Zopiclone—Parosmia—Temozolomide—malignant glioma	0.00258	0.0129	CcSEcCtD
Zopiclone—Hypokinesia—Carmustine—malignant glioma	0.00257	0.0129	CcSEcCtD
Zopiclone—Digestion impaired—Temozolomide—malignant glioma	0.0025	0.0126	CcSEcCtD
Zopiclone—Myopathy—Temozolomide—malignant glioma	0.00239	0.012	CcSEcCtD
Zopiclone—Apathy—Temozolomide—malignant glioma	0.00234	0.0118	CcSEcCtD
Zopiclone—Flat affect—Temozolomide—malignant glioma	0.00232	0.0116	CcSEcCtD
Zopiclone—Stupor—Carmustine—malignant glioma	0.00232	0.0116	CcSEcCtD
Zopiclone—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00226	0.0113	CcSEcCtD
Zopiclone—Menorrhagia—Temozolomide—malignant glioma	0.00226	0.0113	CcSEcCtD
Zopiclone—GABRA5—telencephalon—malignant glioma	0.00226	0.0306	CbGeAlD
Zopiclone—Herpes zoster—Temozolomide—malignant glioma	0.00222	0.0112	CcSEcCtD
Zopiclone—Otitis media—Temozolomide—malignant glioma	0.00215	0.0108	CcSEcCtD
Zopiclone—Hyperaesthesia—Temozolomide—malignant glioma	0.00213	0.0107	CcSEcCtD
Zopiclone—Memory impairment—Temozolomide—malignant glioma	0.00213	0.0107	CcSEcCtD
Zopiclone—Speech disorder—Carmustine—malignant glioma	0.00201	0.0101	CcSEcCtD
Zopiclone—Liver injury—Temozolomide—malignant glioma	0.00199	0.00998	CcSEcCtD
Zopiclone—Accidental injury—Carmustine—malignant glioma	0.00196	0.00982	CcSEcCtD
Zopiclone—Speech disorder—Temozolomide—malignant glioma	0.00195	0.00976	CcSEcCtD
Zopiclone—GABRB2—brainstem—malignant glioma	0.00193	0.0262	CbGeAlD
Zopiclone—Breast pain—Temozolomide—malignant glioma	0.00192	0.00962	CcSEcCtD
Zopiclone—Amenorrhoea—Temozolomide—malignant glioma	0.0019	0.00956	CcSEcCtD
Zopiclone—Thinking abnormal—Carmustine—malignant glioma	0.00189	0.00949	CcSEcCtD
Zopiclone—Viral infection—Temozolomide—malignant glioma	0.00185	0.0093	CcSEcCtD
Zopiclone—PTGS1—endothelium—malignant glioma	0.0018	0.0244	CbGeAlD
Zopiclone—TSPO—embryo—malignant glioma	0.00178	0.0241	CbGeAlD
Zopiclone—Gait disturbance—Carmustine—malignant glioma	0.00177	0.0089	CcSEcCtD
Zopiclone—Coordination abnormal—Carmustine—malignant glioma	0.00176	0.00885	CcSEcCtD
Zopiclone—GABRA2—brainstem—malignant glioma	0.00176	0.0239	CbGeAlD
Zopiclone—Gait disturbance—Temozolomide—malignant glioma	0.00171	0.0086	CcSEcCtD
Zopiclone—GABRG2—telencephalon—malignant glioma	0.00171	0.0232	CbGeAlD
Zopiclone—GABRB2—telencephalon—malignant glioma	0.00171	0.0232	CbGeAlD
Zopiclone—Coordination abnormal—Temozolomide—malignant glioma	0.0017	0.00855	CcSEcCtD
Zopiclone—GABRA1—brainstem—malignant glioma	0.0017	0.0231	CbGeAlD
Zopiclone—Vaginal inflammation—Temozolomide—malignant glioma	0.00167	0.0084	CcSEcCtD
Zopiclone—Depressed level of consciousness—Carmustine—malignant glioma	0.00167	0.00839	CcSEcCtD
Zopiclone—Urinary incontinence—Carmustine—malignant glioma	0.00167	0.00839	CcSEcCtD
Zopiclone—GABRG3—central nervous system—malignant glioma	0.00167	0.0226	CbGeAlD
Zopiclone—PTGS1—blood vessel—malignant glioma	0.00166	0.0225	CbGeAlD
Zopiclone—TSPO—brainstem—malignant glioma	0.00163	0.0221	CbGeAlD
Zopiclone—Neuropathy—Carmustine—malignant glioma	0.00163	0.00816	CcSEcCtD
Zopiclone—Urinary incontinence—Temozolomide—malignant glioma	0.00162	0.00811	CcSEcCtD
Zopiclone—Depressed level of consciousness—Temozolomide—malignant glioma	0.00162	0.00811	CcSEcCtD
Zopiclone—Vaginal infection—Temozolomide—malignant glioma	0.00158	0.00793	CcSEcCtD
Zopiclone—TSPO—retina—malignant glioma	0.00157	0.0213	CbGeAlD
Zopiclone—Neuropathy—Temozolomide—malignant glioma	0.00157	0.00788	CcSEcCtD
Zopiclone—GABRA2—telencephalon—malignant glioma	0.00156	0.0212	CbGeAlD
Zopiclone—Gynaecomastia—Carmustine—malignant glioma	0.00155	0.00777	CcSEcCtD
Zopiclone—Dry eye—Temozolomide—malignant glioma	0.00155	0.00776	CcSEcCtD
Zopiclone—GABRA1—telencephalon—malignant glioma	0.00151	0.0205	CbGeAlD
Zopiclone—Mental disability—Carmustine—malignant glioma	0.0015	0.00754	CcSEcCtD
Zopiclone—Mental disability—Temozolomide—malignant glioma	0.00145	0.00729	CcSEcCtD
Zopiclone—Thrombophlebitis—Carmustine—malignant glioma	0.00145	0.00729	CcSEcCtD
Zopiclone—TSPO—telencephalon—malignant glioma	0.00145	0.0196	CbGeAlD
Zopiclone—Swelling—Carmustine—malignant glioma	0.00142	0.00715	CcSEcCtD
Zopiclone—Ear pain—Temozolomide—malignant glioma	0.00142	0.00714	CcSEcCtD
Zopiclone—Thrombophlebitis—Temozolomide—malignant glioma	0.0014	0.00704	CcSEcCtD
Zopiclone—Injury—Carmustine—malignant glioma	0.00137	0.00686	CcSEcCtD
Zopiclone—GABRG2—medulla oblongata—malignant glioma	0.00134	0.0182	CbGeAlD
Zopiclone—GABRB2—medulla oblongata—malignant glioma	0.00134	0.0182	CbGeAlD
Zopiclone—Amnesia—Carmustine—malignant glioma	0.00134	0.00671	CcSEcCtD
Zopiclone—GABRG3—brain—malignant glioma	0.00132	0.0179	CbGeAlD
Zopiclone—GABRB3—telencephalon—malignant glioma	0.00131	0.0178	CbGeAlD
Zopiclone—Amnesia—Temozolomide—malignant glioma	0.00129	0.00649	CcSEcCtD
Zopiclone—GABRA5—central nervous system—malignant glioma	0.00128	0.0174	CbGeAlD
Zopiclone—Thirst—Temozolomide—malignant glioma	0.00128	0.0064	CcSEcCtD
Zopiclone—Diplopia—Carmustine—malignant glioma	0.00126	0.00631	CcSEcCtD
Zopiclone—GABRG2—midbrain—malignant glioma	0.00123	0.0167	CbGeAlD
Zopiclone—GABRB2—midbrain—malignant glioma	0.00123	0.0167	CbGeAlD
Zopiclone—Diplopia—Temozolomide—malignant glioma	0.00121	0.0061	CcSEcCtD
Zopiclone—Face oedema—Carmustine—malignant glioma	0.00121	0.00609	CcSEcCtD
Zopiclone—GABRG2—spinal cord—malignant glioma	0.0012	0.0163	CbGeAlD
Zopiclone—GABRB2—spinal cord—malignant glioma	0.0012	0.0163	CbGeAlD
Zopiclone—Affect lability—Temozolomide—malignant glioma	0.0012	0.006	CcSEcCtD
Zopiclone—GABRA3—central nervous system—malignant glioma	0.00119	0.0162	CbGeAlD
Zopiclone—GABRA1—medulla oblongata—malignant glioma	0.00119	0.0161	CbGeAlD
Zopiclone—Ataxia—Carmustine—malignant glioma	0.00118	0.00593	CcSEcCtD
Zopiclone—Face oedema—Temozolomide—malignant glioma	0.00117	0.00588	CcSEcCtD
Zopiclone—Mood swings—Temozolomide—malignant glioma	0.00115	0.00577	CcSEcCtD
Zopiclone—Hypokalaemia—Carmustine—malignant glioma	0.00114	0.00574	CcSEcCtD
Zopiclone—Ataxia—Temozolomide—malignant glioma	0.00114	0.00573	CcSEcCtD
Zopiclone—TSPO—medulla oblongata—malignant glioma	0.00114	0.0154	CbGeAlD
Zopiclone—Dehydration—Temozolomide—malignant glioma	0.00113	0.00567	CcSEcCtD
Zopiclone—Dry skin—Temozolomide—malignant glioma	0.00111	0.00559	CcSEcCtD
Zopiclone—Muscular weakness—Carmustine—malignant glioma	0.00111	0.00556	CcSEcCtD
Zopiclone—Hypokalaemia—Temozolomide—malignant glioma	0.00111	0.00555	CcSEcCtD
Zopiclone—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00109	0.00549	CcSEcCtD
Zopiclone—Dysphagia—Carmustine—malignant glioma	0.00109	0.00545	CcSEcCtD
Zopiclone—GABRA1—midbrain—malignant glioma	0.00109	0.0147	CbGeAlD
Zopiclone—Muscular weakness—Temozolomide—malignant glioma	0.00107	0.00538	CcSEcCtD
Zopiclone—GABRA1—spinal cord—malignant glioma	0.00106	0.0144	CbGeAlD
Zopiclone—Dysphagia—Temozolomide—malignant glioma	0.00105	0.00527	CcSEcCtD
Zopiclone—TSPO—midbrain—malignant glioma	0.00104	0.0141	CbGeAlD
Zopiclone—GABRB3—medulla oblongata—malignant glioma	0.00103	0.014	CbGeAlD
Zopiclone—GABRA5—brain—malignant glioma	0.00102	0.0138	CbGeAlD
Zopiclone—TSPO—spinal cord—malignant glioma	0.00101	0.0138	CbGeAlD
Zopiclone—Bronchitis—Temozolomide—malignant glioma	0.00101	0.00507	CcSEcCtD
Zopiclone—Dysuria—Temozolomide—malignant glioma	0.000982	0.00493	CcSEcCtD
Zopiclone—GABRG2—central nervous system—malignant glioma	0.000973	0.0132	CbGeAlD
Zopiclone—GABRB2—central nervous system—malignant glioma	0.000973	0.0132	CbGeAlD
Zopiclone—Pollakiuria—Temozolomide—malignant glioma	0.00097	0.00487	CcSEcCtD
Zopiclone—Erectile dysfunction—Temozolomide—malignant glioma	0.000967	0.00485	CcSEcCtD
Zopiclone—Depression—Carmustine—malignant glioma	0.000966	0.00485	CcSEcCtD
Zopiclone—Photosensitivity reaction—Temozolomide—malignant glioma	0.000958	0.00481	CcSEcCtD
Zopiclone—Weight increased—Temozolomide—malignant glioma	0.000955	0.00479	CcSEcCtD
Zopiclone—GABRG2—cerebellum—malignant glioma	0.000951	0.0129	CbGeAlD
Zopiclone—GABRB2—cerebellum—malignant glioma	0.000951	0.0129	CbGeAlD
Zopiclone—Weight decreased—Temozolomide—malignant glioma	0.00095	0.00477	CcSEcCtD
Zopiclone—Neuropathy peripheral—Carmustine—malignant glioma	0.00095	0.00476	CcSEcCtD
Zopiclone—GABRA3—brain—malignant glioma	0.000947	0.0128	CbGeAlD
Zopiclone—Stomatitis—Carmustine—malignant glioma	0.000944	0.00474	CcSEcCtD
Zopiclone—GABRB3—midbrain—malignant glioma	0.000944	0.0128	CbGeAlD
Zopiclone—Urinary tract infection—Carmustine—malignant glioma	0.000942	0.00472	CcSEcCtD
Zopiclone—Depression—Temozolomide—malignant glioma	0.000933	0.00468	CcSEcCtD
Zopiclone—GABRB3—spinal cord—malignant glioma	0.000921	0.0125	CbGeAlD
Zopiclone—Neuropathy peripheral—Temozolomide—malignant glioma	0.000918	0.0046	CcSEcCtD
Zopiclone—Stomatitis—Temozolomide—malignant glioma	0.000912	0.00458	CcSEcCtD
Zopiclone—Urinary tract infection—Temozolomide—malignant glioma	0.00091	0.00457	CcSEcCtD
Zopiclone—GABRA2—central nervous system—malignant glioma	0.000889	0.0121	CbGeAlD
Zopiclone—GABRA2—cerebellum—malignant glioma	0.000869	0.0118	CbGeAlD
Zopiclone—Hypoaesthesia—Carmustine—malignant glioma	0.000865	0.00434	CcSEcCtD
Zopiclone—Hallucination—Carmustine—malignant glioma	0.000865	0.00434	CcSEcCtD
Zopiclone—GABRA1—central nervous system—malignant glioma	0.000859	0.0116	CbGeAlD
Zopiclone—Oedema peripheral—Carmustine—malignant glioma	0.000857	0.0043	CcSEcCtD
Zopiclone—Hepatitis—Temozolomide—malignant glioma	0.00084	0.00422	CcSEcCtD
Zopiclone—GABRA1—cerebellum—malignant glioma	0.000839	0.0114	CbGeAlD
Zopiclone—Hallucination—Temozolomide—malignant glioma	0.000836	0.0042	CcSEcCtD
Zopiclone—Hypoaesthesia—Temozolomide—malignant glioma	0.000836	0.0042	CcSEcCtD
Zopiclone—CYP2E1—telencephalon—malignant glioma	0.000836	0.0113	CbGeAlD
Zopiclone—Pharyngitis—Temozolomide—malignant glioma	0.000834	0.00419	CcSEcCtD
Zopiclone—Oedema peripheral—Temozolomide—malignant glioma	0.000828	0.00415	CcSEcCtD
Zopiclone—TSPO—central nervous system—malignant glioma	0.000823	0.0112	CbGeAlD
Zopiclone—PTGS1—telencephalon—malignant glioma	0.000805	0.0109	CbGeAlD
Zopiclone—TSPO—cerebellum—malignant glioma	0.000804	0.0109	CbGeAlD
Zopiclone—Erythema multiforme—Temozolomide—malignant glioma	0.000795	0.00399	CcSEcCtD
Zopiclone—Tinnitus—Temozolomide—malignant glioma	0.000784	0.00393	CcSEcCtD
Zopiclone—GABRG2—brain—malignant glioma	0.000772	0.0105	CbGeAlD
Zopiclone—GABRB2—brain—malignant glioma	0.000772	0.0105	CbGeAlD
Zopiclone—Alopecia—Carmustine—malignant glioma	0.000768	0.00386	CcSEcCtD
Zopiclone—Chills—Temozolomide—malignant glioma	0.000754	0.00378	CcSEcCtD
Zopiclone—GABRB3—central nervous system—malignant glioma	0.000747	0.0101	CbGeAlD
Zopiclone—Alopecia—Temozolomide—malignant glioma	0.000743	0.00373	CcSEcCtD
Zopiclone—Back pain—Carmustine—malignant glioma	0.000732	0.00367	CcSEcCtD
Zopiclone—GABRB3—cerebellum—malignant glioma	0.00073	0.0099	CbGeAlD
Zopiclone—Dysgeusia—Temozolomide—malignant glioma	0.000716	0.00359	CcSEcCtD
Zopiclone—Vision blurred—Carmustine—malignant glioma	0.000713	0.00358	CcSEcCtD
Zopiclone—Tremor—Carmustine—malignant glioma	0.000709	0.00356	CcSEcCtD
Zopiclone—Back pain—Temozolomide—malignant glioma	0.000708	0.00355	CcSEcCtD
Zopiclone—GABRA2—brain—malignant glioma	0.000706	0.00957	CbGeAlD
Zopiclone—Anaemia—Carmustine—malignant glioma	0.0007	0.00351	CcSEcCtD
Zopiclone—Agitation—Carmustine—malignant glioma	0.000696	0.00349	CcSEcCtD
Zopiclone—Vision blurred—Temozolomide—malignant glioma	0.000689	0.00346	CcSEcCtD
Zopiclone—Tremor—Temozolomide—malignant glioma	0.000685	0.00344	CcSEcCtD
Zopiclone—GABRA1—brain—malignant glioma	0.000682	0.00925	CbGeAlD
Zopiclone—Ill-defined disorder—Temozolomide—malignant glioma	0.000679	0.00341	CcSEcCtD
Zopiclone—Anaemia—Temozolomide—malignant glioma	0.000676	0.00339	CcSEcCtD
Zopiclone—Agitation—Temozolomide—malignant glioma	0.000672	0.00337	CcSEcCtD
Zopiclone—Angioedema—Temozolomide—malignant glioma	0.000668	0.00335	CcSEcCtD
Zopiclone—Malaise—Temozolomide—malignant glioma	0.00066	0.00331	CcSEcCtD
Zopiclone—Vertigo—Temozolomide—malignant glioma	0.000657	0.0033	CcSEcCtD
Zopiclone—CYP2E1—medulla oblongata—malignant glioma	0.000657	0.00891	CbGeAlD
Zopiclone—Convulsion—Carmustine—malignant glioma	0.000656	0.00329	CcSEcCtD
Zopiclone—Hypertension—Carmustine—malignant glioma	0.000654	0.00328	CcSEcCtD
Zopiclone—TSPO—brain—malignant glioma	0.000653	0.00886	CbGeAlD
Zopiclone—Palpitations—Temozolomide—malignant glioma	0.000646	0.00324	CcSEcCtD
Zopiclone—Chest pain—Carmustine—malignant glioma	0.000644	0.00323	CcSEcCtD
Zopiclone—Myalgia—Carmustine—malignant glioma	0.000644	0.00323	CcSEcCtD
Zopiclone—Anxiety—Carmustine—malignant glioma	0.000642	0.00322	CcSEcCtD
Zopiclone—Convulsion—Temozolomide—malignant glioma	0.000634	0.00318	CcSEcCtD
Zopiclone—Hypertension—Temozolomide—malignant glioma	0.000632	0.00317	CcSEcCtD
Zopiclone—Confusional state—Carmustine—malignant glioma	0.000623	0.00313	CcSEcCtD
Zopiclone—Myalgia—Temozolomide—malignant glioma	0.000623	0.00313	CcSEcCtD
Zopiclone—Anxiety—Temozolomide—malignant glioma	0.000621	0.00311	CcSEcCtD
Zopiclone—Discomfort—Temozolomide—malignant glioma	0.000615	0.00309	CcSEcCtD
Zopiclone—Infection—Carmustine—malignant glioma	0.000614	0.00308	CcSEcCtD
Zopiclone—Dry mouth—Temozolomide—malignant glioma	0.000609	0.00306	CcSEcCtD
Zopiclone—Tachycardia—Carmustine—malignant glioma	0.000603	0.00303	CcSEcCtD
Zopiclone—Confusional state—Temozolomide—malignant glioma	0.000602	0.00302	CcSEcCtD
Zopiclone—Anaphylactic shock—Temozolomide—malignant glioma	0.000597	0.003	CcSEcCtD
Zopiclone—Infection—Temozolomide—malignant glioma	0.000593	0.00298	CcSEcCtD
Zopiclone—GABRB3—brain—malignant glioma	0.000593	0.00804	CbGeAlD
Zopiclone—Anorexia—Carmustine—malignant glioma	0.000589	0.00295	CcSEcCtD
Zopiclone—CYP2E1—spinal cord—malignant glioma	0.000586	0.00794	CbGeAlD
Zopiclone—Hyperhidrosis—Temozolomide—malignant glioma	0.000577	0.0029	CcSEcCtD
Zopiclone—Anorexia—Temozolomide—malignant glioma	0.000569	0.00286	CcSEcCtD
Zopiclone—PTGS1—spinal cord—malignant glioma	0.000564	0.00765	CbGeAlD
Zopiclone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000563	0.00282	CcSEcCtD
Zopiclone—Insomnia—Carmustine—malignant glioma	0.000559	0.0028	CcSEcCtD
Zopiclone—Paraesthesia—Carmustine—malignant glioma	0.000555	0.00278	CcSEcCtD
Zopiclone—Dyspnoea—Carmustine—malignant glioma	0.000551	0.00276	CcSEcCtD
Zopiclone—Somnolence—Carmustine—malignant glioma	0.000549	0.00276	CcSEcCtD
Zopiclone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000544	0.00273	CcSEcCtD
Zopiclone—Insomnia—Temozolomide—malignant glioma	0.00054	0.00271	CcSEcCtD
Zopiclone—Decreased appetite—Carmustine—malignant glioma	0.000537	0.00269	CcSEcCtD
Zopiclone—Paraesthesia—Temozolomide—malignant glioma	0.000536	0.00269	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Carmustine—malignant glioma	0.000533	0.00268	CcSEcCtD
Zopiclone—Dyspnoea—Temozolomide—malignant glioma	0.000532	0.00267	CcSEcCtD
Zopiclone—Somnolence—Temozolomide—malignant glioma	0.000531	0.00266	CcSEcCtD
Zopiclone—Constipation—Carmustine—malignant glioma	0.000528	0.00265	CcSEcCtD
Zopiclone—Pain—Carmustine—malignant glioma	0.000528	0.00265	CcSEcCtD
Zopiclone—Dyspepsia—Temozolomide—malignant glioma	0.000526	0.00264	CcSEcCtD
Zopiclone—Decreased appetite—Temozolomide—malignant glioma	0.000519	0.0026	CcSEcCtD
Zopiclone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000515	0.00259	CcSEcCtD
Zopiclone—Fatigue—Temozolomide—malignant glioma	0.000515	0.00258	CcSEcCtD
Zopiclone—Pain—Temozolomide—malignant glioma	0.000511	0.00256	CcSEcCtD
Zopiclone—Constipation—Temozolomide—malignant glioma	0.000511	0.00256	CcSEcCtD
Zopiclone—Feeling abnormal—Carmustine—malignant glioma	0.000509	0.00255	CcSEcCtD
Zopiclone—Gastrointestinal pain—Carmustine—malignant glioma	0.000505	0.00253	CcSEcCtD
Zopiclone—Feeling abnormal—Temozolomide—malignant glioma	0.000492	0.00247	CcSEcCtD
Zopiclone—Abdominal pain—Carmustine—malignant glioma	0.000488	0.00245	CcSEcCtD
Zopiclone—Body temperature increased—Carmustine—malignant glioma	0.000488	0.00245	CcSEcCtD
Zopiclone—Gastrointestinal pain—Temozolomide—malignant glioma	0.000488	0.00245	CcSEcCtD
Zopiclone—CYP2E1—central nervous system—malignant glioma	0.000475	0.00644	CbGeAlD
Zopiclone—Urticaria—Temozolomide—malignant glioma	0.000474	0.00238	CcSEcCtD
Zopiclone—Abdominal pain—Temozolomide—malignant glioma	0.000472	0.00237	CcSEcCtD
Zopiclone—Body temperature increased—Temozolomide—malignant glioma	0.000472	0.00237	CcSEcCtD
Zopiclone—CYP2E1—cerebellum—malignant glioma	0.000465	0.0063	CbGeAlD
Zopiclone—PTGS1—central nervous system—malignant glioma	0.000458	0.00621	CbGeAlD
Zopiclone—Hypersensitivity—Carmustine—malignant glioma	0.000455	0.00228	CcSEcCtD
Zopiclone—CYP2C8—brain—malignant glioma	0.000448	0.00608	CbGeAlD
Zopiclone—Asthenia—Carmustine—malignant glioma	0.000443	0.00222	CcSEcCtD
Zopiclone—Hypersensitivity—Temozolomide—malignant glioma	0.00044	0.00221	CcSEcCtD
Zopiclone—Asthenia—Temozolomide—malignant glioma	0.000428	0.00215	CcSEcCtD
Zopiclone—Diarrhoea—Carmustine—malignant glioma	0.000423	0.00212	CcSEcCtD
Zopiclone—Pruritus—Temozolomide—malignant glioma	0.000422	0.00212	CcSEcCtD
Zopiclone—Dizziness—Carmustine—malignant glioma	0.000409	0.00205	CcSEcCtD
Zopiclone—Diarrhoea—Temozolomide—malignant glioma	0.000409	0.00205	CcSEcCtD
Zopiclone—Dizziness—Temozolomide—malignant glioma	0.000395	0.00198	CcSEcCtD
Zopiclone—Vomiting—Carmustine—malignant glioma	0.000393	0.00197	CcSEcCtD
Zopiclone—Rash—Carmustine—malignant glioma	0.00039	0.00195	CcSEcCtD
Zopiclone—Dermatitis—Carmustine—malignant glioma	0.000389	0.00195	CcSEcCtD
Zopiclone—Headache—Carmustine—malignant glioma	0.000387	0.00194	CcSEcCtD
Zopiclone—CYP3A4—central nervous system—malignant glioma	0.000382	0.00519	CbGeAlD
Zopiclone—Vomiting—Temozolomide—malignant glioma	0.00038	0.0019	CcSEcCtD
Zopiclone—CYP2E1—brain—malignant glioma	0.000377	0.00512	CbGeAlD
Zopiclone—Rash—Temozolomide—malignant glioma	0.000376	0.00189	CcSEcCtD
Zopiclone—Dermatitis—Temozolomide—malignant glioma	0.000376	0.00189	CcSEcCtD
Zopiclone—Headache—Temozolomide—malignant glioma	0.000374	0.00188	CcSEcCtD
Zopiclone—Nausea—Carmustine—malignant glioma	0.000367	0.00184	CcSEcCtD
Zopiclone—PTGS1—brain—malignant glioma	0.000363	0.00493	CbGeAlD
Zopiclone—Nausea—Temozolomide—malignant glioma	0.000355	0.00178	CcSEcCtD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	7.79e-05	0.000901	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—PTGS1—malignant glioma	7.79e-05	0.000901	CbGpPWpGaD
Zopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	7.76e-05	0.000898	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	7.71e-05	0.000892	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.66e-05	0.000887	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—TFRC—malignant glioma	7.59e-05	0.000878	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—TFRC—malignant glioma	7.38e-05	0.000853	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—MDM2—malignant glioma	7.33e-05	0.000848	CbGpPWpGaD
Zopiclone—GABRB2—Transmission across Chemical Synapses—RAF1—malignant glioma	7.3e-05	0.000845	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—TFRC—malignant glioma	7.24e-05	0.000838	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—RTEL1—malignant glioma	7.16e-05	0.000828	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—TFRC—malignant glioma	7.12e-05	0.000824	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—MDM2—malignant glioma	7.12e-05	0.000823	CbGpPWpGaD
Zopiclone—GABRA5—Transmission across Chemical Synapses—RAF1—malignant glioma	7.09e-05	0.000821	CbGpPWpGaD
Zopiclone—CYP2C8—Biological oxidations—GSTP1—malignant glioma	7.08e-05	0.000819	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—TFRC—malignant glioma	7.07e-05	0.000818	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	6.99e-05	0.000809	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—MDM2—malignant glioma	6.99e-05	0.000809	CbGpPWpGaD
Zopiclone—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	6.98e-05	0.000808	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.97e-05	0.000807	CbGpPWpGaD
Zopiclone—GABRA3—Transmission across Chemical Synapses—RAF1—malignant glioma	6.96e-05	0.000806	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—TFRC—malignant glioma	6.94e-05	0.000803	CbGpPWpGaD
Zopiclone—GABRA1—Ion channel transport—RAF1—malignant glioma	6.91e-05	0.000799	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—MDM2—malignant glioma	6.87e-05	0.000795	CbGpPWpGaD
Zopiclone—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	6.84e-05	0.000792	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—MDM2—malignant glioma	6.82e-05	0.00079	CbGpPWpGaD
Zopiclone—GABRB3—Transmission across Chemical Synapses—RAF1—malignant glioma	6.8e-05	0.000787	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	6.78e-05	0.000784	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.77e-05	0.000784	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	6.7e-05	0.000775	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—BRAF—malignant glioma	6.7e-05	0.000775	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	6.68e-05	0.000773	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	6.68e-05	0.000773	CbGpPWpGaD
Zopiclone—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	6.68e-05	0.000773	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—STAT3—malignant glioma	6.67e-05	0.000772	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—MDM2—malignant glioma	6.67e-05	0.000772	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.65e-05	0.00077	CbGpPWpGaD
Zopiclone—GABRG3—Neuronal System—RAF1—malignant glioma	6.65e-05	0.000769	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.64e-05	0.000768	CbGpPWpGaD
Zopiclone—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	6.55e-05	0.000758	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.54e-05	0.000756	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—BRAF—malignant glioma	6.51e-05	0.000753	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.49e-05	0.000751	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.45e-05	0.000746	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	6.41e-05	0.000741	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	6.39e-05	0.00074	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—BRAF—malignant glioma	6.39e-05	0.000739	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.38e-05	0.000738	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—COX8A—malignant glioma	6.36e-05	0.000736	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.33e-05	0.000732	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—BRAF—malignant glioma	6.28e-05	0.000727	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—BRAF—malignant glioma	6.24e-05	0.000722	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.22e-05	0.00072	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.18e-05	0.000715	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—BRAF—malignant glioma	6.13e-05	0.000709	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	6.07e-05	0.000702	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.07e-05	0.000702	CbGpPWpGaD
Zopiclone—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	5.86e-05	0.000679	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	5.86e-05	0.000678	CbGpPWpGaD
Zopiclone—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	5.84e-05	0.000675	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—RTEL1—malignant glioma	5.82e-05	0.000674	CbGpPWpGaD
Zopiclone—CYP2C9—Biological oxidations—GSTP1—malignant glioma	5.76e-05	0.000667	CbGpPWpGaD
Zopiclone—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	5.68e-05	0.000657	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—MDM2—malignant glioma	5.61e-05	0.000649	CbGpPWpGaD
Zopiclone—GABRB2—Neuronal System—RAF1—malignant glioma	5.59e-05	0.000647	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	5.57e-05	0.000645	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTT1—malignant glioma	5.48e-05	0.000634	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—MDM2—malignant glioma	5.45e-05	0.000631	CbGpPWpGaD
Zopiclone—GABRA5—Neuronal System—RAF1—malignant glioma	5.43e-05	0.000629	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	5.42e-05	0.000628	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—ASMT—malignant glioma	5.41e-05	0.000626	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—BRAF—malignant glioma	5.36e-05	0.00062	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—MDM2—malignant glioma	5.35e-05	0.00062	CbGpPWpGaD
Zopiclone—GABRA3—Neuronal System—RAF1—malignant glioma	5.34e-05	0.000617	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.3e-05	0.000614	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.29e-05	0.000612	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—MDM2—malignant glioma	5.26e-05	0.000609	CbGpPWpGaD
Zopiclone—GABRA2—Neuronal System—RAF1—malignant glioma	5.24e-05	0.000607	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—MDM2—malignant glioma	5.23e-05	0.000605	CbGpPWpGaD
Zopiclone—GABRB3—Neuronal System—RAF1—malignant glioma	5.21e-05	0.000603	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—PTGS1—malignant glioma	5.14e-05	0.000594	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—MDM2—malignant glioma	5.13e-05	0.000594	CbGpPWpGaD
Zopiclone—GABRG2—Neuronal System—RAF1—malignant glioma	5.12e-05	0.000592	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	5.11e-05	0.000592	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—BCAN—malignant glioma	5.09e-05	0.000589	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.95e-05	0.000573	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—COX8A—malignant glioma	4.76e-05	0.00055	CbGpPWpGaD
Zopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	4.65e-05	0.000538	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—MDM2—malignant glioma	4.49e-05	0.000519	CbGpPWpGaD
Zopiclone—GABRA1—Neuronal System—RAF1—malignant glioma	4.47e-05	0.000517	CbGpPWpGaD
Zopiclone—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	4.3e-05	0.000498	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.16e-05	0.000482	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—COX8A—malignant glioma	4.11e-05	0.000476	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—IDH2—malignant glioma	4.1e-05	0.000475	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—ASMT—malignant glioma	4.04e-05	0.000468	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.03e-05	0.000466	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.87e-05	0.000447	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP2B6—malignant glioma	3.86e-05	0.000446	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—RTEL1—malignant glioma	3.84e-05	0.000445	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—BCAN—malignant glioma	3.8e-05	0.00044	CbGpPWpGaD
Zopiclone—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.8e-05	0.00044	CbGpPWpGaD
Zopiclone—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.75e-05	0.000434	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.67e-05	0.000425	CbGpPWpGaD
Zopiclone—GABRG3—Transmembrane transport of small molecules—RAF1—malignant glioma	3.57e-05	0.000413	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—IDH1—malignant glioma	3.53e-05	0.000408	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—ASMT—malignant glioma	3.5e-05	0.000404	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.42e-05	0.000395	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—SPHK1—malignant glioma	3.41e-05	0.000395	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—COX8A—malignant glioma	3.35e-05	0.000387	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CYP2C18—malignant glioma	3.34e-05	0.000387	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—BCAN—malignant glioma	3.29e-05	0.00038	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.15e-05	0.000365	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—IDH2—malignant glioma	3.06e-05	0.000355	CbGpPWpGaD
Zopiclone—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	3.01e-05	0.000348	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.99e-05	0.000346	CbGpPWpGaD
Zopiclone—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	2.92e-05	0.000338	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP2B6—malignant glioma	2.88e-05	0.000333	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.87e-05	0.000332	CbGpPWpGaD
Zopiclone—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.87e-05	0.000332	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—ASMT—malignant glioma	2.84e-05	0.000329	CbGpPWpGaD
Zopiclone—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.82e-05	0.000326	CbGpPWpGaD
Zopiclone—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.8e-05	0.000324	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.78e-05	0.000322	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.77e-05	0.000321	CbGpPWpGaD
Zopiclone—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.75e-05	0.000318	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTT1—malignant glioma	2.7e-05	0.000313	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—BCAN—malignant glioma	2.67e-05	0.000309	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—IDH2—malignant glioma	2.65e-05	0.000307	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—IDH1—malignant glioma	2.64e-05	0.000305	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—SPHK1—malignant glioma	2.55e-05	0.000295	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.52e-05	0.000292	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CYP2C18—malignant glioma	2.5e-05	0.000289	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.5e-05	0.000289	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP2B6—malignant glioma	2.49e-05	0.000288	CbGpPWpGaD
Zopiclone—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.4e-05	0.000278	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—BCHE—malignant glioma	2.36e-05	0.000273	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—SLC5A5—malignant glioma	2.33e-05	0.000269	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—IDH1—malignant glioma	2.28e-05	0.000264	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—COX8A—malignant glioma	2.21e-05	0.000255	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—SPHK1—malignant glioma	2.2e-05	0.000255	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.2e-05	0.000255	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.18e-05	0.000252	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CYP2C18—malignant glioma	2.16e-05	0.00025	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—IDH2—malignant glioma	2.16e-05	0.000249	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.04e-05	0.000236	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.03e-05	0.000235	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.03e-05	0.000235	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTT1—malignant glioma	2.02e-05	0.000234	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.9e-05	0.00022	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTGS1—malignant glioma	1.89e-05	0.000219	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—ASMT—malignant glioma	1.88e-05	0.000217	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—GSTP1—malignant glioma	1.87e-05	0.000217	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.85e-05	0.000215	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—IDH1—malignant glioma	1.85e-05	0.000215	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CAT—malignant glioma	1.82e-05	0.000211	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SPHK1—malignant glioma	1.79e-05	0.000208	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.79e-05	0.000207	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—BCAN—malignant glioma	1.76e-05	0.000204	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—BCHE—malignant glioma	1.76e-05	0.000204	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.76e-05	0.000203	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTT1—malignant glioma	1.75e-05	0.000202	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—SLC5A5—malignant glioma	1.74e-05	0.000201	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—NCOR1—malignant glioma	1.72e-05	0.000199	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.66e-05	0.000192	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTGS1—malignant glioma	1.64e-05	0.000189	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.63e-05	0.000189	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—BCHE—malignant glioma	1.52e-05	0.000176	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.51e-05	0.000175	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.5e-05	0.000174	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.46e-05	0.000169	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—IDH2—malignant glioma	1.42e-05	0.000165	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTT1—malignant glioma	1.42e-05	0.000164	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.42e-05	0.000164	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.41e-05	0.000163	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—CAV1—malignant glioma	1.4e-05	0.000162	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—GSTP1—malignant glioma	1.4e-05	0.000162	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CAT—malignant glioma	1.36e-05	0.000158	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.34e-05	0.000155	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.34e-05	0.000155	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTGS1—malignant glioma	1.33e-05	0.000154	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.33e-05	0.000154	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—NCOR1—malignant glioma	1.29e-05	0.000149	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CG—malignant glioma	1.28e-05	0.000148	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—BCHE—malignant glioma	1.24e-05	0.000143	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PPARG—malignant glioma	1.23e-05	0.000143	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.23e-05	0.000142	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.22e-05	0.000142	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—IDH1—malignant glioma	1.22e-05	0.000141	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—GSTP1—malignant glioma	1.21e-05	0.00014	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SPHK1—malignant glioma	1.18e-05	0.000137	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CAT—malignant glioma	1.18e-05	0.000136	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.16e-05	0.000134	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.16e-05	0.000134	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.15e-05	0.000133	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CD—malignant glioma	1.12e-05	0.00013	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—NCOR1—malignant glioma	1.11e-05	0.000129	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—CAV1—malignant glioma	1.05e-05	0.000121	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.99e-06	0.000116	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—GSTP1—malignant glioma	9.85e-06	0.000114	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CB—malignant glioma	9.8e-06	0.000113	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PTGS2—malignant glioma	9.71e-06	0.000112	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CAT—malignant glioma	9.59e-06	0.000111	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CG—malignant glioma	9.56e-06	0.000111	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTT1—malignant glioma	9.37e-06	0.000108	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PPARG—malignant glioma	9.22e-06	0.000107	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—CAV1—malignant glioma	9.07e-06	0.000105	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—NCOR1—malignant glioma	9.05e-06	0.000105	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTGS1—malignant glioma	8.78e-06	0.000102	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.66e-06	0.0001	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PTEN—malignant glioma	8.47e-06	9.8e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CD—malignant glioma	8.4e-06	9.72e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CG—malignant glioma	8.26e-06	9.56e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—BCHE—malignant glioma	8.17e-06	9.45e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—SLC5A5—malignant glioma	8.07e-06	9.33e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PPARG—malignant glioma	7.97e-06	9.22e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—CAV1—malignant glioma	7.38e-06	8.54e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CB—malignant glioma	7.32e-06	8.47e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CD—malignant glioma	7.26e-06	8.4e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTGS2—malignant glioma	7.26e-06	8.4e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.05e-06	8.16e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.72e-06	7.78e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—GSTP1—malignant glioma	6.5e-06	7.52e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PPARG—malignant glioma	6.49e-06	7.51e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CB—malignant glioma	6.33e-06	7.32e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PTEN—malignant glioma	6.33e-06	7.32e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CAT—malignant glioma	6.32e-06	7.32e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTGS2—malignant glioma	6.27e-06	7.26e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—PIK3CA—malignant glioma	5.97e-06	6.91e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—NCOR1—malignant glioma	5.97e-06	6.91e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.91e-06	6.84e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PTEN—malignant glioma	5.47e-06	6.33e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.15e-06	5.96e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTGS2—malignant glioma	5.1e-06	5.91e-05	CbGpPWpGaD
Zopiclone—PTGS1—Metabolism—AKT1—malignant glioma	4.88e-06	5.65e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—CAV1—malignant glioma	4.87e-06	5.63e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—PIK3CA—malignant glioma	4.46e-06	5.17e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PTEN—malignant glioma	4.45e-06	5.15e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.43e-06	5.13e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PPARG—malignant glioma	4.28e-06	4.95e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.9e-06	4.51e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.86e-06	4.46e-05	CbGpPWpGaD
Zopiclone—CYP2E1—Metabolism—AKT1—malignant glioma	3.65e-06	4.22e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.4e-06	3.93e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTGS2—malignant glioma	3.37e-06	3.9e-05	CbGpPWpGaD
Zopiclone—CYP2C8—Metabolism—AKT1—malignant glioma	3.15e-06	3.65e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.14e-06	3.63e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PTEN—malignant glioma	2.94e-06	3.4e-05	CbGpPWpGaD
Zopiclone—CYP2C9—Metabolism—AKT1—malignant glioma	2.57e-06	2.97e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.07e-06	2.4e-05	CbGpPWpGaD
Zopiclone—CYP3A4—Metabolism—AKT1—malignant glioma	1.69e-06	1.96e-05	CbGpPWpGaD
